Dr Reddy's to Launch Sanofi's RSV Drug in India
Apr 28, 2025 17:16
Dr Reddy's Laboratories has partnered with Sanofi Healthcare to introduce Beyfortus, a novel drug for RSV prevention in newborns and infants in India. The medication is expected to launch in the second quarter of the current fiscal year.
New Delhi, Apr 28 (PTI) Dr Reddy's Laboratories on Monday said it has expanded its partnership with Sanofi Healthcare to introduce a novel drug for the prevention of lower respiratory tract disease in newborns.
The company plans to introduce Beyfortus, which contains the monoclonal antibody, nirsevimab, in a prefilled injection used for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants.
The medication is also administered in children up to 24 months of age, who remain vulnerable to severe RSV disease through their second RSV season.
RSV is a highly contagious virus that can lead to serious respiratory illness in infants.
Under the arrangement, Dr Reddy's will have exclusive rights from Sanofi to promote and distribute Beyfortus in India, the Hyderabad-based drugmaker said in a statement.
The announcement follows Dr Reddy's successful exclusive distribution partnership with Sanofi for their portfolio of vaccines in India last year.
Dr Reddy's is expected to launch Beyfortus in India in the second quarter of the current fiscal year.
"Beyfortus enables the access of healthcare professionals and parents to an improved drug in the prevention of RSV," Dr Reddy's Laboratories CEO Branded Markets (India and Emerging Markets) MV Ramana said.
Bringing Beyfortus to India is a pivotal step in the company's mission to protect every child from immunisation preventable diseases like RSV, Nitya Padmanabhan, Head of Sanofi Vaccines (India), said.
Beyfortus has been approved for use in the European Union, the US, China, Japan, and many other countries around the world.
In India, it received marketing authorisation approval in June last year from the Central Drugs Standard Control Organisation (CDSCO).
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
Cathay Cargo Sees Growth in SE Asia, India...
Cathay Cargo director discusses Southeast Asia as a major market and exciting...
Stock Markets Fall on Global Weakness, FII...
Sensex and Nifty decline amid weak global cues, foreign fund outflows, and US-India...
Delhi Air Quality: Jahangirpuri AQI at 498...
Delhi air quality worsens, Jahangirpuri records AQI of 498, falling in the severe...
Rupee Hits Record Low: INR vs USD at 90.58
Rupee falls to a new all-time low of 90.58 against the US dollar amid trade deal...
DRI Seizes Red Sanders Worth Rs 6.26 Cr, 4...
DRI seizes 15 MT of red sanders worth Rs 6.26 crore in Delhi, arrests 4. Illegal export...
UAE Fund to Invest ₹1,000 Cr in Kerala Startups
UAE-based Feeder Fund to invest ₹1,000 crore in Kerala startups over 3 years. Boost...
ECL Aims for 58 MT Output, Mine Closures Planned
Eastern Coalfields Ltd (ECL) targets 58 MT output, plans closure of six underground...
India: Export Potential in Russia
300 Indian products have huge export potential in Russia. Engineering, pharma, agri,...
Gold & Silver Rally: Inflation Data in Focus
Gold and silver prices rally amid inflation data focus. Analysts eye central bank...
India Ranks 3rd in Global AI Vibrancy Index
India ranks 3rd in Stanford University's Global AI Vibrancy tool, surpassing advanced...
Read More »